The Valley Desk

NCT02181634 · Interventional trial

Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma

Overall registry status Completed

Phase 2

Conditions Cholangiocarcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov